BIOC - Biocept, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue5,068.6633,223.096609.909133.415
Cost of Revenue9,345.1226,920.1114,596.1582,170.548
Gross Profit-4,276.459-3,697.015-3,986.249-2,037.133
Operating Expenses
Research Development3,364.7472,713.3672,857.774,497.79
Selling General and Administrative13,533.511,614.6559,566.7847,339.001
Non Recurring----
Others----
Total Operating Expenses26,243.36921,248.13317,020.71214,007.339
Operating Income or Loss-21,174.706-18,025.037-16,410.803-13,873.924
Income from Continuing Operations
Total Other Income/Expenses Net-431.407-372.232-537.115-1,990.616
Earnings Before Interest and Taxes-21,174.706-18,025.037-16,410.803-13,873.924
Interest Expense-482.623-525.88-639.547-1,789.68
Income Before Tax-21,606.113-18,397.269-16,947.918-15,864.54
Income Tax Expense7.6242.0531.6081.506
Minority Interest----
Net Income From Continuing Ops-21,613.737-18,399.322-16,949.526-15,866.046
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-21,613.737-18,399.322-16,949.526-15,866.046
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-21,613.737-18,399.322-16,949.526-15,866.046